SPS
AVDL

Susquehanna Portfolio Strategies’s Avadel Pharmaceuticals AVDL Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,552
Closed -$292K – 984
2025
Q4 		$292K Hold
13,552
– – ﹤0.01% 886
2025
Q3 		$207K Buy
+13,552
New +$176K ﹤0.01% 977

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Susquehanna Portfolio Strategies's AVDL Position: Q1 2026 in Review

Susquehanna Portfolio Strategies sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 13,552 shares — an estimated $292K sold.

Susquehanna Portfolio Strategies first reported a position in AVDL in Q3 2025 and held it in 2 quarters. The position peaked at $292K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Susquehanna Portfolio Strategies reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 13,552 Avadel Pharmaceuticals shares in Q1 2026, an estimated $292K.
  • Susquehanna Portfolio Strategies first reported a position in Avadel Pharmaceuticals in Q3 2025 and held it in 2 quarters.
  • Susquehanna Portfolio Strategies's Avadel Pharmaceuticals position peaked at $292K in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.